Clean Core and CNL sign Cost Share Project under CNRI to advance Thorium-Based ANEEL™ Fuel

Udgivet den 26-09-2024  |  kl. 13:00  |  

Clean Core Thorium Energy is verifying and validating their ANEEL™ fuel technology through research enabled by Canadian Nuclear Laboratories' Canadian Nuclear Research Initiative

Canadian Nuclear Laboratories facilities - Photo © Canadian Nuclear Laboratories

CHICAGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Clean Core Thorium Energy (Clean Core) is pleased to announce that it has been accepted to participate in Canadian Nuclear Laboratories' (CNL) Canadian Nuclear Research Initiative (CNRI). Through the program, CNL and Clean Core will work to verify and validate the computer codes and analytical models employed in the design and safety analysis of Clean Core's ANEEL™ fuel which will enable its accelerated commercialization for the Canada Deuterium Uranium (CANDU) reactors.

Clean Core has developed and patented a fuel, named the ANEEL™ fuel, made of thorium and enriched uranium. The fuel is designed for use in existing pressurized heavy water reactors (PHWR) and CANDU reactors with flexibility across enrichment levels (LEU+ to HALEU) as well as fuel designs (such as 19-pin and 37-pin). The fuel retains the same external dimensions as the currently used natural uranium (NU) fuel and leverages a high burnup, once-through fuel cycle. With no modifications to the reactor or its core, the ANEEL™ fuel derives several advantages over the currently used low burnup, NU fuel including improved safety, economics, and operations as well as reduced nuclear waste volumes and proliferation resistance.

Launched in 2019, the CNRI program was established by CNL to accelerate the deployment of nuclear technologies in Canada by enabling research and development, and connecting the nuclear industry with the facilities and expertise within Canada's national nuclear laboratories. Among the many benefits of the program, participants optimize resources, share technical knowledge, receive cost share funding and gain access to CNL's expertise to help advance the commercialization of nuclear technologies.

"Clean Core recognizes this as a key collaboration for the ANEEL™ fuel by leveraging the technical capabilities and existing domain expertise at CNL for development and assessment of various fuel, physics and thermohydraulic models," says Mehul Shah, CEO and Founder of Clean Core. "This collaboration will meaningfully accelerate the deployment of the ANEEL™ fuel, which can impact the Canadian and global nuclear industries."

Clean Core completed initial design studies, and recently announced the successful conclusion of the Phase 1 Pre-licensing Vendor Design Review process with the Canadian Nuclear Safety Commission. Additionally, Clean Core signed a Strategic Partnership Project Agreement with the US DOE and is currently performing irradiation testing and qualification of the ANEEL fuel in the Advanced Test Reactor at Idaho National Labs with burnup targets of up to 60 GWd/T.

About Clean Core Thorium Energy

Clean Core Thorium Energy is a nuclear fuel company exploring thorium-driven nuclear innovations. Clean Core's patented nuclear fuel technology (called the ANEEL™ fuel) is comprised of thorium and enriched uranium (LEU+ to HALEU), which is capable of improving the safety and cost-efficiency of pressurized heavy-water reactors. The ANEEL™ fuel is a novel solution to safety, waste, and proliferation concerns in today's nuclear plants.

Learn more at https://cleancore.energy/. Follow us on social media: LinkedIn and X.

Clean Core Contact:

Milan Shah
Chief Operating Officer
milan@cleancore.energy 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/907e1d40-e8e4-4214-819e-1be40dd0050d


\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed